SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-021171
Filing Date
2024-08-13
Accepted
2024-08-13 16:35:21
Documents
2
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 form3-08132024_080818.html 3  
1 form3-08132024_080818.xml 3 1733
2 ex24-08132024_080818.htm EX-24 6797
  Complete submission text file 0001415889-24-021171.txt   9976
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PASSAGE BIO, INC. 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address
Forman Mark S (Reporting) CIK: 0001922353 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40928 | Film No.: 241202269